ITC slips below 20-day EMA; heres what F&O data suggests ITC slips below 20-day EMA; heres what F&O data suggests Vinayak Gangule / Friday, February 12, 2021 / Article rating: 3.7 The stock of ITC Limited plunged nearly 4 per cent on the last trading session of the week. Read onto know more about what the F&O data suggests about the stock.
Stock that rises 530 per cent from March lows, what should be its next course of action? Stock that rises 530 per cent from March lows, what should be its next course of action? Vinayak Gangule / Friday, February 12, 2021 / Article rating: 5.0 The stock has witnessed a nearly 530 per cent upside momentum from the low of Rs 15.85, which was registered on March 30, 2020 and has given 46.22 per cent returns from year-to-date.
CDSL gives trendline breakout CDSL gives trendline breakout Vinayak Gangule / Friday, February 12, 2021 / Article rating: 4.2 The stock's relative strength index (RSI) has reached its highest value in the last 14-days, which is bullish. Also, it has managed to close above the 60 mark after a span of almost 23 trading sessions. The MACD is above the zero line and signal line. The MACD histogram suggests bullish momentum.
Weekly Economic Update Weekly Economic Update DSIJ Intelligence / Friday, February 12, 2021 / Article rating: 4.0 Economic weekly for February 12, 2021.
Biocon Biologics & Viatris receive nod for Kixelle-biosimilar insulin Aspart from EC Biocon Biologics & Viatris receive nod for Kixelle-biosimilar insulin Aspart from EC DSIJ Intelligence / Friday, February 12, 2021 / Article rating: 4.0 Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that Kixelle, a biosimilar Insulin Aspart co-developed with Viatris Inc has received marketing authorisation approval from European Commission. The authorisation granted by EC is valid in all the EU member states.
Alembic Pharmaceuticals rises over 3 per cent on receiving USFDA nod for Treprostinil injection Alembic Pharmaceuticals rises over 3 per cent on receiving USFDA nod for Treprostinil injection DSIJ Intelligence / Friday, February 12, 2021 / Article rating: 3.5 Alembic Pharmaceuticals today announced that its wholly-owned subsidiary, Alembic Global Holding SA has received final approval from United States Food & Drug Administration (USFDA) for Treprostinil injection.
Strides Pharma Science jumps 4 per cent on receiving USFDA approval Strides Pharma Science jumps 4 per cent on receiving USFDA approval Abhinav Lahoti / Friday, February 12, 2021 / Article rating: 4.5 Strides Pharma Science Ltd informed on Friday during the market hours that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for Prednisone tablets USP, 10 mg & 20 mg from USFDA.
Buzzing small-cap: Prima Plastics hits new 52-week high Buzzing small-cap: Prima Plastics hits new 52-week high Apurva Joshi / Friday, February 12, 2021 / Article rating: 5.0 On Friday, Prima Plastics Limited surged as much as 19.8 per cent and made a fresh 52-week high of Rs 93.40. Later, it got closed 13.6 per cent higher at Rs 88.60 from its previous close of Rs 77.95. From its 52-week low level of Rs 23.80 recorded in March 2020, the stock has recovered approximately 292 per cent.
RITES trades flat on bagging consultancy order from Haryana Rail Infrastructure Development Corporation RITES trades flat on bagging consultancy order from Haryana Rail Infrastructure Development Corporation DSIJ Intelligence / Friday, February 12, 2021 / Article rating: 4.0 Railway consultancy firm, RITES Limited announced that it has in a consortium, emerged as an L-1 bidder for a general consultancy order from Haryana Rail Infrastructure Development Corporation Limited for their Haryana Orbital Rail Corridor (HORC).
Sun Pharma share price slips 2 per cent post settlement order by SEBI Sun Pharma share price slips 2 per cent post settlement order by SEBI DSIJ Intelligence / Friday, February 12, 2021 / Article rating: 4.4 The shares of the drug manufacturer, Sun Pharmaceutical Industries Ltd had initially touched its 52-week high during the early trade on Friday but soon, slipped by almost 2 per cent after Securities & Exchange Board of India (SEBI) issued an order for settling charges made by a whistleblower.